0->The descriptions align with content from a designated section of Clinical Trial Reports (CTRs), encapsulating pertinent trial details.
----------
1->

Enhance the Clinical Trial Report section for an expert audience by preserving the original intent and ensuring factual accuracy. Revise to either succinctly summarize key elements or to expand with precise definitions and clarifications for improved comprehension, with penalties for errors. Strive for superior clarity, brevity, and explicitness, exceeding the initial descriptions' clarity.
----------
2->"

Refine and optimize Clinical Trial Reports (CTRs) for expert evaluation, emphasizing clarity, brevity, and explicitness. Maintain the original intent and key message, either by distilling critical information for conciseness or by providing precise definitions and additional clarifications, ensuring accuracy and avoiding misinformation.
----------
3->

Refine the Clinical Trial Report (CTR) section for expert readers by maintaining the original intent and ensuring factual accuracy. Revisions may be concise, capturing the core essence, or elaborate, incorporating precise definitions and additional clarifications to deepen understanding, with penalties for errors. Aim for enhanced clarity, conciseness, and explicitness, surpassing the clarity of the initial instructions.
----------
4->

Refine Clinical Trial Reports (CTRs) for an expert readership by maintaining the original intent and message accuracy. Condense or elaborate upon the content, incorporating precise definitions and clarifications as needed, while avoiding inaccuracies. Aim for enhanced clarity, conciseness, and explicitness, surpassing the initial instructions' clarity.
----------
